One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 350,000 shares of Pfizer Inc. (NYSE: PFE) on Friday, as the price of this fund was up over 2% in the day’s session. It is also up a fair amount in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) added 351,289 shares of Pfizer. At Friday’s closing price, this would have valued this purchase at roughly $16.4 million. This is only a small fraction of the total holdings. The fund is up 42% over the past 52 weeks.
Check out all the ARK Invest buys for Friday:
|ARKG||DYNS||DYNAMICS SPECIAL PURPOSE||49,500|
|ARKQ||ACIC||ATLAS CREST INVESTMENT||190,900|
|ARKQ||KTOS||KRATOS DEFENSE & SECURITY SOLUTIONS||59,400|
|ARKX||PRNT||3D PRINTING ETF||11,293|
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.